Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related antibody Nurulimab (Anti-CTLA-4 / CD152) For research use only.
Not for use in humans.

Nurulimab (Anti-CTLA-4 / CD152)

Synonyms:

Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.

Nurulimab (Anti-CTLA-4 / CD152)

Purity & Quality Control

≥99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.

Product Details

CAS No. 2168561-20-2
Molecular Weight 145.34
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) supplier | purchase Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) cost | Nurulimab (Anti-CTLA-4 / CD152) manufacturer | order Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) distributor